首页> 外文OA文献 >Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV

【2h】

Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV

机译：聚乙二醇干扰素联合利巴韦林联合治疗24周后，合并感染HBV / HCV / HDV / HIV的患者可完全治愈HBV-HDV合并感染

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gozlan Joel; Lacombe Karine; Gault Elyanne; Raguin Gilles; Girard Pierre-Marie;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV. [J] . Gozlan J, Lacombe K, Gault E, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2009,第2期

机译：在合并感染HBV / HCV / HDV / HIV的患者中，与聚乙二醇化干扰素和利巴韦林联合治疗24周后，HBV-HDV合并感染的完全治愈。
2. REP 2139 monotherapy and combination therapy with pegylated interferon: safety and potent reduction of HBsAg and HDV RNA in Caucasian Patients with chronic HBV/HDV co-infection [J] . Bazinet M., Pantea V., Cebotarescu V., Journal of viral hepatitis. . 2015,第Suppla2期

机译：REP 2139单药和聚乙二醇干扰素联合治疗：高加索慢性HBV / HDV合并感染白种人患者的安全性和有效降低HBsAg和HDV RNA
3. Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy. [J] . Antonio Rivero-Juarez, Karin Neukam, Pablo Labarga, Journal of Infection . 2014,第4期

机译：从聚乙二醇干扰素/利巴韦林治疗的HIV / HCV合并感染患者中，持续的病毒学应答可以从治疗开始4周的总病毒载量下降率中预测。
4. Efficacy of combination therapy of interferon-α and ribavirin for HIV/HCV co-infected patients in a six-year follow-up [C] . AiPing Wang, ChunYang Wen, Fang Gao 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：六年随访中干扰素-α和利巴韦林联合治疗对HIV / HCV合并感染患者的疗效
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran [O] . Khashayar Hesamizadeh, Ahmad Tavakoli, Mehri Nikbin 2019

机译：聚乙二醇干扰素联合利巴韦林联合治疗伊朗HCV单感染和HCV / HIV合并感染患者
7. Peg-interferon Plus Ribavirin Combination Therapy in HCV Mono-infected and HCV/HIV Co-infected Patients in Iran [O] . Khashayar Hesamizadeh, Ahmad Tavakoli, Mehri Nikbin 2019

机译：PEG-Welleron Plus伊朗HCV单声道和HCV / HIV COR感染患者中的利巴韦林组合疗法

Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV

著录项

引文网络

相似文献

相关主题

期刊订阅